Cancer
Ranked #1 regionally and rated high-performing in colon cancer surgery, lung cancer surgery, gynecological cancer surgery, and more.
RESEARCH
Discovery May Help Prevent Drug Resistance Before it Starts
Researchers at UC Davis identified a mechanism that may explain how cancers develop resistance to BET inhibitors, a promising class of anti-tumor drugs. The study found that when BET inhibitors target BRD4, cancer cells increase production of a related protein, BRD2, allowing tumors to survive and grow.
Clinical Science
New Trial Explores High-Risk Lymphoma Treatment
A new clinical trial at UC Davis Comprehensive Cancer Center is testing a treatment approach for people with high-risk diffuse large B-cell lymphoma. The trial combines targeted immunotherapy and chemotherapy, with researchers hoping the sequence may give patients a better chance at beating the aggressive cancer.
RESEARCH
Species-Specific ‘Shedding’ May Distort Testing of Cancer Drugs
A new study published in the Journal of Biological Chemistry from UC Davis Comprehensive Cancer Center finds that TIGIT (T cell immunoreceptor with Ig and ITIM domains) triggers a different response in rhesus macaques compared to humans. The study shows that rhesus macaques shed TIGIT from the surfaces of immune cells when exposed to plasmin.
Education and Engagement
Latest News
Clinical Resources
Refer a Patient
We welcome the opportunity to partner with you in caring for your patient.
Browse Specialties
Our specialists are available when the need arises. Learn more about a specific health specialty.
Clinical Studies
The goal of clinical studies at UC Davis Health is to discover and share knowledge to advance health.
Awards and Recognitions
Ranked among the best in 6 specialties
A U.S. News & World Report best hospital in cancer care, cardiology, heart & vascular surgery, geriatrics, neurology & neurosurgery, orthopedics, and pulmonology & lung surgery.
Regionally ranked #1
U.S. News & World Report ranked UC Davis Medical Center among the region’s best in cancer care.
World-class cancer care
One of ~59 U.S. cancer centers designated “comprehensive” by the National Cancer Institute.
Member of the National Comprehensive Cancer Network
UC Davis Comprehensive Cancer Center is a member of the National Comprehensive Cancer Network, an alliance of the world’s leading cancer centers.
Accredited cancer programs
Cancer programs at UC Davis Comprehensive Cancer Center are accredited by the Commission on Cancer of the American College of Surgeons. Cancer programs, like those at the cancer center, voluntarily participate in the commission’s Approvals Program and meet 36 standards of quality patient care.
Ranked high-performing in leukemia, lymphoma & myeloma treatment
U.S. News & World Report rated UC Davis Medical Center high-performing in treating leukemia, lymphoma & myeloma.
Ranked high-performing in colon cancer surgery
U.S. News & World Report rated UC Davis Medical Center high-performing in colon cancer surgery.
Ranked high-performing in lung cancer surgery
U.S. News & World Report rated UC Davis Medical Center high-performing in lung cancer surgery.
Ranked high-performing in gynecological cancer surgery
U.S. News & World Report rated UC Davis Medical Center high-performing in gynecological cancer surgery.
The nation’s highest nursing honor
UC Davis Medical Center has received Magnet® recognition, the nation’s highest honor for nursing excellence.
Ranked Sacramento’s #1 hospital
Ranked Sacramento’s #1 hospital by U.S. News, and recognized in 23 types of care including acute kidney failure, cancer care, cardiology, heart & vascular surgery, COPD, colon cancer surgery, diabetes, diabetes & endocrinology, ear, nose & throat surgery, gastroenterology & GI surgery, geriatrics, gynecological cancer surgery, heart arrhythmia, heart attack, heart failure, hip fracture, hip replacement, leukemia, lymphoma & myeloma, lung cancer surgery, neurology & neurosurgery, orthopedics, pneumonia, pulmonology & lung surgery and stroke.